Data

A single arm phase II study using magnetic resonance imaging (MRI) to select patients with early breast cancer for omission of post-operative radiotherapy (ANZ 1002 PROSPECT)

Health Data Australia Contributor Records
Mann, Bruce ; Breast Cancer Trials (BCT) ; Breast Cancer Trials (BCT)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58080/DVZY-1Z98&rft.title=A single arm phase II study using magnetic resonance imaging (MRI) to select patients with early breast cancer for omission of post-operative radiotherapy (ANZ 1002 PROSPECT)&rft.identifier=http://doi.org/10.58080/DVZY-1Z98&rft.publisher=Breast Cancer Trials (BCT)&rft.description=Dataset of 201 women with histologically confirmed, unifocal, unilateraly invasive early breast cancer selected to omit radiotherapy by MRI before trial entry. The primary objective was ipsilateral invasive recurrence rate in the breast at 5 years.&rft.creator=Mann, Bruce &rft.creator=Breast Cancer Trials (BCT) &rft.creator=Breast Cancer Trials (BCT) &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12610000810011&rft_subject=Cancer therapy (excl. chemotherapy and radiation therapy)&rft.type=dataset&rft.language=English Access the data

Full description

Dataset of 201 women with histologically confirmed, unifocal, unilateraly invasive early breast cancer selected to omit radiotherapy by MRI before trial entry. The primary objective was ipsilateral invasive recurrence rate in the breast at 5 years.

Notes

HeSANDA 1.0.0

Issued: 2023

Available: 2023

This dataset is part of a larger collection

Click to explore relationships graph
Subjects

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Breast Cancer Trials (BCT)

ROR : https://ror.org/00j1vsg87

Identifiers